Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Resource Type
Article
Authors
Martín, Miguel ; Zielinski, Christoph ; Ruiz-Borrego, Manuel ; Carrasco, Eva ; Ciruelos, Eva M. ; Muñoz, Montserrat ; Bermejo, Begoña ; Margelí, Mireia ; Csöszi, Tibor ; Antón, Antonio ; Turner, Nicholas ; Casas, María I. ; Morales, Serafín ; Alba, Emilio ; Calvo, Lourdes ; de la Haba-Rodríguez, Juan ; Ramos, Manuel ; Murillo, Laura ; Santaballa, Ana ; Alonso-Romero, José L. ; Sánchez-Rovira, Pedro ; Corsaro, Massimo ; Huang, Xin ; Thallinger, Christiane ; Kahan, Zsuzsanna ; Gil-Gil, Miguel
Source
In European Journal of Cancer June 2022 168:12-24
Subject
Language
ISSN
0959-8049